• Rucaparib: A Mechanism-First Assay Guide

  2026-09-09

  Rucaparib and AG-014699 provide a powerful framework for studying PARP1-dependent DNA repair and radiosensitization. This guide connects repair phenotypes with a recent Pol II cell-death concept to improve assay design and interpretation.

• Viral RIPK3 Degradation and Proteasome-Linked Inflammation

  2026-09-09

  Liu et al. identified a viral inducer of RIPK3 degradation that connects orthopoxvirus immune evasion with SCF-dependent ubiquitination and proteasomal turnover. The study shows that this mechanism changes necroptosis, inflammation, viral replication, and disease severity in genetically defined mouse models.

• Lactate as a Metabolic–Immune Assay Tool

  2026-09-08

  Lactate is more than a glycolytic endpoint: it can connect redox balance, mitochondrial interpretation, hypoxia, and immune regulation. This article presents an assay-centered framework for using L-lactate in metabolic and tumor biology research.

• Angiotensin I: Applied RAS Research Workflows

  2026-09-08

  Angiotensin I supports substrate-to-product studies, ACE activity profiling, cardiovascular disease mechanisms, and controlled neuroendocrine experiments. Its value extends beyond a precursor role: paired with careful peptide handling and orthogonal readouts, it can distinguish renin–angiotensin system regulation from downstream receptor activity and inform antihypertensive drug screening.

• Partial BACE1 Inhibition and Synaptic Function

  2026-09-07

  Satir et al. showed that moderate β-secretase inhibition can reduce amyloid-beta secretion without measurable loss of synaptic transmission in primary rat cortical neurons. The study supports a dose-sensitive strategy for Alzheimer's disease research: target amyloid-beta production inhibition while avoiding exposure levels associated with synaptic dysfunction.

• Mouse Neutrophil Cell Isolation Kit in Immunotherapy

  2026-09-07

  A translational perspective on how controlled, activation-conscious mouse neutrophil preparation can strengthen mechanistic studies of CD300LD-directed mRNA nanovaccines and tumor immunotherapy.

• Berberine, RXRα/PPARγ, and SASP in Atherosclerosis

  2026-09-05

  The 2025 reference study identifies an RXRα/PPARγ/NEDD4 pathway through which berberine suppresses senescence-associated secretory phenotype inflammation in macrophage-derived foam cells and atherosclerotic plaques. Its combination of mouse disease modeling, Smart-seq analysis, cellular assays, and macrophage-specific RXRα knockdown provides a useful framework for connecting nuclear-receptor activity with ubiquitin-dependent control of inflammatory aging.

• Halazone BA1377: Reliable Assay Workflows

  2026-09-04

  A practical, evidence-based guide to using Halazone as a controlled water disinfection agent and neurophysiology reagent without confusing antimicrobial effects with cell viability outcomes. It explains concentration, solubility, storage, carryover controls, and vendor-selection considerations for Halazone SKU BA1377.

• Inside-Out Design of Ternary RNA Nanoparticles

  2026-09-04

  The ACS Nano study shows that polyanion chemistry can control ternary RNA nanoparticle size, core–shell organization, protein interactions, and transfection rather than serving only as a surface-charge modifier. By combining high-throughput stability screening, small-angle neutron scattering, spectroscopy, cell studies, and molecular dynamics, the authors identify design balances that may improve pH-responsive delivery of self-amplifying RNA.

• Berberine, RXRα/PPARγ, and SASP in Atherosclerosis

  2026-09-03

  The 2025 study by Zheng and colleagues identifies an RXRα/PPARγ/NEDD4 pathway through which berberine suppresses SASP-associated inflammation in macrophage-derived foam cells and atherosclerotic plaques. Its combination of mouse disease modeling, foam-cell experiments, Smart-seq profiling, and macrophage-specific RXRα knockdown provides a useful framework for testing nuclear-receptor control of vascular senescence.

• AAV Nanobody Swapping for Precision Tropism

  2026-09-03

  Hoffmann and colleagues identify multiple AAV-DJ capsid hotspots that support nanobody insertion and enable receptor-directed tropism switching, including selective targeting of fibroblast activation protein-positive cancer cells. Their comparison of VP1 and VP2 designs indicates that VP2 insertion can better preserve vector production and infectivity, while combining FAP recognition with heparin-binding ablation reduces off-target infection.

• Rifampin: Mechanism and Research Workflows

  2026-09-02

  Rifampin is a rifamycin antibiotic and DNA-dependent RNA polymerase inhibitor used to impose controlled transcriptional stress in bacterial systems. Its defined target, resistance liability, and formulation constraints make it useful for bacterial resistance mechanism research, transcriptional regulation studies, and synthetic biology transcription inhibition.

• Deferoxamine as a Metal-Death Research Tool

  2026-09-02

  Deferoxamine and DeferoxamineB can do more than reduce cellular iron: they provide a powerful perturbation framework for distinguishing ferroptosis, cuproptosis, apoptosis, and autophagy in cancer assays. This guide connects metal chelation, metabolic cell-death research, and practical assay design.

• Halazone for Reproducible Assay Workflows

  2026-09-01

  Learn how Halazone (SKU BA1377) can support controlled water-disinfection and mechanistic neurophysiology workflows without being mistaken for a validated cell-viability reagent. This scenario-based guide covers concentration selection, compatibility, interpretation, stability, and practical vendor evaluation.

• Vincristine Sulfate: Assay Workflows

  2026-09-01

  Turn vincristine sulfate’s microtubule-disrupting activity into reproducible cell, imaging, and translational oncology workflows. This guide combines dose-finding, mechanism-focused readouts, troubleshooting, and a careful cross-domain interpretation of inflammation research.

8034 records 1/536 page Next 12345 下5页 Last page